Investments Ab Kdev - Net Worth and Insider Trading
Investments Ab Kdev Net Worth
The estimated net worth of Investments Ab Kdev is at least $290,917 dollars as of 2024-09-20. Investments Ab Kdev is the 10% Owner of Aprea Therapeutics Inc and owns about 99,629 shares of Aprea Therapeutics Inc (APRE) stock worth over $290,917. Details can be seen in Investments Ab Kdev's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Investments Ab Kdev has not made any transactions after 2020-07-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Investments Ab Kdev
Investments Ab Kdev Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Investments Ab Kdev owns 1 companies in total, including Aprea Therapeutics Inc (APRE) .
Click here to see the complete history of Investments Ab Kdev’s form 4 insider trades.
Insider Ownership Summary of Investments Ab Kdev
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| APRE | Aprea Therapeutics Inc | 2020-07-07 | 10 percent owner |
Investments Ab Kdev Latest Holdings Summary
Investments Ab Kdev currently owns a total of 1 stock. Investments Ab Kdev owns 99,629 shares of Aprea Therapeutics Inc (APRE) as of July 7, 2020, with a value of $290,917.
Latest Holdings of Investments Ab Kdev
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| APRE | Aprea Therapeutics Inc | 2020-07-07 | 99,629 | 2.92 | 290,917 |
Holding Weightings of Investments Ab Kdev
Investments Ab Kdev Form 4 Trading Tracker
According to the SEC Form 4 filings, Investments Ab Kdev has made a total of 2 transactions in Aprea Therapeutics Inc (APRE) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Aprea Therapeutics Inc is the sale of 12,085 shares on July 7, 2020, which brought Investments Ab Kdev around $8 Million.
Insider Trading History of Investments Ab Kdev
- 1
Investments Ab Kdev Trading Performance
Investments Ab Kdev Ownership Network
Investments Ab Kdev Owned Company Details
What does Aprea Therapeutics Inc do?
Who are the key executives at Aprea Therapeutics Inc?
Investments Ab Kdev is the 10 percent owner of Aprea Therapeutics Inc. Other key executives at Aprea Therapeutics Inc include President & CEO Oren Gilad , SrVP/CFO/Prin. Fin &Acctg. Off John P. Hamill , and director & President & CEO Christian S Schade .
Aprea Therapeutics Inc (APRE) Insider Trades Summary
Over the past 18 months, Investments Ab Kdev made no insider transaction in Aprea Therapeutics Inc (APRE). Other recent insider transactions involving Aprea Therapeutics Inc (APRE) include a net purchase of 16,957 shares made by Bernd R. Seizinger , a net purchase of 6,860 shares made by Henneman John B Iii , and a net purchase of 2,000 shares made by Oren Gilad .
In summary, during the past 3 months, insiders sold 0 shares of Aprea Therapeutics Inc (APRE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aprea Therapeutics Inc (APRE) were sold and 26,827 shares were bought by its insiders, resulting in a net purchase of 26,827 shares.
Aprea Therapeutics Inc (APRE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aprea Therapeutics Inc Insider Transactions
Investments Ab Kdev Mailing Address
Above is the net worth, insider trading, and ownership report for Investments Ab Kdev. You might contact Investments Ab Kdev via mailing address: Tomtebodavagen 23a, Solna V7 Se 171 65.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
